MSK Experts Present Notable Clinical Research at the AACR Virtual Annual Meeting II

AACR II Meeting

Courtesy of: American Association for Cancer Research (AACR)

Thousands of oncology experts from around the world will tune in virtually June 22-24 for the American Association for Cancer Research (AACR) Virtual Annual Meeting II.

Memorial Sloan Kettering (MSK) researchers will lead and present some of the most notable research at the meeting and are available to comment on topics such as clinical trials, tumor biology, genetics, targeted therapies, and more. MSK expert Zsofia K. Stadler, MD was featured in the meeting’s press program on June 19, presenting research about the prevalence of germline mutations in young adults with cancer. The findings will be released in a virtual poster session on June 22. 

Additionally, MSK is proud to announce that Jedd D. Wolchok, MD, PhD will receive the AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research. The AACR and Bristol-Myers Squibb established this award in 1996 to recognize outstanding achievements in clinical cancer research. The award honors Dr. Joseph H. Burchenal, Honorary Member and Past President of the AACR, and a major figure in clinical cancer research. MSK experts Roberta Zappasodi, PhD and Jenny Yaohua Xue, BS will also receive the 2020 Women in Cancer Research (WICR) Scholar Award.

For more information and to set up interviews, contact [email protected] and [email protected]. The virtual meeting is free and available to stream live by registering here. Follow the meeting live on Twitter using the hashtag #AACR20 and follow MSK on Twitter at @sloan_kettering.